Recurrent Gonococcemia Reveiling X-linked Properdin Deficiency: A Novel Case Report - Top-Institutions - MDSpire

Recurrent Gonococcemia Reveiling X-linked Properdin Deficiency: A Novel Case Report

  • By

  • Colombe Chedal-Anglay

  • William Vindrios

  • April 10, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    National Institute of Allergy and Infectious Diseases (NIAID), NIH
    National Institute of Allergy and Infectious Diseases (NIAID), NIH

    Bethesda, MD

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Complement Biology

  • #2

    Massachusetts General Hospital (MGH) Infectious Diseases Division
    Massachusetts General Hospital (MGH) Infectious Diseases Division

    Boston, MA

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Sexually Transmitted Infections

  • #3

    Johns Hopkins University School of Medicine, Division of Infectious Diseases
    Johns Hopkins University School of Medicine, Division of Infectious Diseases

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Complement Disorders

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Sexually Transmitted Diseases

  • #5

    Mayo Clinic, Department of Infectious Diseases
    Mayo Clinic, Department of Infectious Diseases

    Rochester, MN

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Complement Deficiencies

Original Source(s)

Recurrent Gonococcemia Reveiling X-linked Properdin Deficiency: A Novel Case Report

  • by Colombe Chedal-Anglay, William Vindrios

  • April 10, 2025

Related Content

Progress and prospects for herpesvirus vaccination using gB antigens

Makary Resigns as FDA Commissioner Following Policy Disputes

Transition follows disputes over vaccine policy, food additive regulation, and flavored vaping product authorization

Assessing PEPFAR’s Health Spillover Effects Beyond HIV: An Update